{
 "PrintNo":"S3497","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-01-29T16:58:09.155467Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-29","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":885,"Name":"Robert Ortt","Short":"ORTT"}],
 "Title":"Prohibits co-pays for certain short term opioid drug prescriptions",
 "Summary":"Prohibits insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription which was initially written for seven days or less.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3216, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription",
 "SameAsPrintNo":"A3903-2021","PreviousVersions":["S3666-2017","S279-2019"]
}